Cannabis Compliance & Policy

In the next decade, the cannabis business is expected to reach $85 billion in revenue in North America alone. Cannabis investment is booming, with large and small companies considering manufacturing, sales and service opportunities for hemp, a non-psychoactive form of cannabis, and hemp-derived cannabidiol (CBD). In spite of its growing popularity and business potential, there are ongoing questions about how companies should lawfully pursue the sale, use and transport of some hemp and CBD products. The way CBD is regarded by the federal government's regulatory agencies is shifting, and cannabis service providers have liability concerns.

Our Cannabis Compliance and Policy team helps businesses address legal uncertainties in a rapidly-evolving industry that faces conflicting regulatory frameworks. We communicate with key regulatory agencies that govern CBD policy and have longstanding relationships with law and policy-makers and regulatory bodies. So we can help our clients anticipate and adapt to regulatory and policy challenges as they enter or navigate the cannabis market.

With the support of our public law and policy, regulatory, corporate, trade, private equity, investment management and employment practices, we provide legal advice and strategies for compliance with existing cannabis laws in an effort to reshape the industry’s legal landscape.